$Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence$

Hypofractionated Radiotherapy in Gynecologic Malignancies—A Peek into the Upcoming Evidence

Radiotherapy (RT) has a fundamental role in the treatment of gynecologic malignancies, including cervical and uterine cancers. Hypofractionated RT has gained popularity in many cancer sites, boosted by technological advances in treatment delivery and image verification. Hypofractionated RT uptake wa...

Full description

Bibliographic Details
Main Authors:	Razan Amjad, Nataliya Moldovan, Hamid Raziee, Eric Leung, David D’Souza, Lucas C. Mendez
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Cancers
Subjects:	hypofractionated radiotherapy gynecologic malignancies cervical cancer uterine cancer universal access to radiotherapy
Online Access:	https://www.mdpi.com/2072-6694/16/2/362

Similar Items

Hypofractionated Radiotherapy for Post-Operative Breast Cancer Patients at Delta Hospital - an Evaluation of Clinical Experience
by: Parvin Akhter Banu, et al.
Published: (2015-01-01)

Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01)

Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions
by: Huayong Jiang, et al.
Published: (2021-12-01)

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review
by: Lei Liu, et al.
Published: (2020-01-01)

Hypofractionation: The standard for external beam breast irradiation
by: Adrian Murray Brunt, et al.
Published: (2023-06-01)

Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis
by: Dong-Yun Kim, et al.
Published: (2021-02-01)

Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
by: Hoon Sik Choi, et al.
Published: (2019-06-01)

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial
by: Geumju Park, et al.
Published: (2021-10-01)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
by: Pavol Dubinsky, et al.
Published: (2023-07-01)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
by: Barra S, et al.
Published: (2018-03-01)

Conventional versus different hypofractionated radiotherapy dosage schedules in postmastectomy advanced breast cancer
by: Neeraj Jain, et al.
Published: (2022-01-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

Efficacy and safety analysis of hypofractionated and conventional fractionated radiotherapy in postoperative breast cancer patients
by: Yongkai Lu, et al.
Published: (2024-02-01)

Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic
by: Olivera Ivanov, et al.
Published: (2022-05-01)

Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
by: Giuseppe Sanguineti, et al.
Published: (2019-01-01)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
by: Jiahua Lyu, et al.
Published: (2019-07-01)

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial
by: Lucas C. Mendez, et al.
Published: (2020-10-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
by: Elisabetta Parisi, et al.
Published: (2023-02-01)

Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan
by: Wei-Kai Chuang, et al.
Published: (2022-08-01)

Effect of hypofractionated radiotherapy on lung functions in breast cancer patients
by: Enass A.A. Rezk, et al.
Published: (2023-01-01)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
by: Michael Laursen, et al.
Published: (2018-06-01)

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients
by: Digesù C, et al.
Published: (2018-10-01)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
by: Sean Mahase, et al.
Published: (2020-12-01)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
by: Georges Noël, et al.
Published: (2013-09-01)

Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
by: Siyer Roohani, et al.
Published: (2022-09-01)

The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas
by: Mateusz Jacek Spałek, et al.
Published: (2021-03-01)

Randomized Prospective Study Comparing Conventional Versus Hypofractionated Adjuvant Radiotherapy in Node-Positive Breast Cancer
by: Mai Atef, et al.
Published: (2019-12-01)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
by: Maria Chiara Lo Greco, et al.
Published: (2023-06-01)

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
by: Marcin Miszczyk, et al.
Published: (2022-09-01)

Accelerated Hypofractionated Whole Breast Radiotherapy for Early Breast Cancer; A Randomized Phase III Clinical Trial
by: Sare Hosseini, et al.
Published: (2020-05-01)

Comparing the effects of conventional and hypofractionated radiotherapies on early skin toxicity and cosmetic outcomes after breast cancer conserving surgery
by: Amouzegar Hashemi F, et al.
Published: (2012-12-01)

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
by: Hua Ye, et al.
Published: (2021-04-01)

Radiation Boost After Adjuvant Whole Breast Radiotherapy: Does Evidence Support Practice for Close Margin and Altered Fractionation?
by: Stephanie Gulstene, et al.
Published: (2020-06-01)

Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients
by: Nicosia L, et al.
Published: (2022-09-01)

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
by: Nadia Gisella Di Muzio, et al.
Published: (2021-10-01)

Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
by: Eileen Samuel, et al.
Published: (2024-02-01)

Hypofractionated Radiotherapy for Stage I Squamous Cell Carcinoma Glottis: An Experience with 60Gy in 20 Fractions
by: Pushpaja Ullattil, et al.
Published: (2023-07-01)